Numerai’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-123,241
Closed -$351K 676
2025
Q3
$351K Buy
+123,241
New +$422K 0.05% 404
2023
Q2
Sell
-52,372
Closed -$611K 188
2023
Q1
$611K Sell
52,372
-270,534
-84% -$3.45M 0.2% 109
2022
Q4
$3.43M Buy
+322,906
New +$3.12M 2.34% 10

Other funds holding HCAT

Numerai's HCAT Position: Q4 2025 in Review

Numerai sold out of Health Catalyst (HCAT) in Q4 2025, closing a stake of 123,241 shares — an estimated $351K sold.

Numerai first reported a position in HCAT in Q4 2022 and held it in 3 quarters. The position peaked at $3.43M in Q4 2022. 136 funds tracked by Wall St. Rank hold HCAT as of Q4 2025.

  • Numerai reported no remaining Health Catalyst position as of Q4 2025 after selling out during the quarter.
  • Numerai sold 123,241 Health Catalyst shares in Q4 2025, an estimated $351K.
  • Numerai first reported a position in Health Catalyst in Q4 2022 and held it in 3 quarters.
  • Numerai's Health Catalyst position peaked at $3.43M in Q4 2022.
  • 136 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2025.

Based on Numerai's 13F filing for Q4 2025, filed 17 Feb 2026.